Found 18 matching trials
A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer PHASE1 Objectives
* Primary: To evaluate the safety and tolerability of FG-3019 i...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) PHASE2 This is a Phase 2, open-label, single arm trial of pamrevlumab (FG-3019) to...
Show More Location
David Geffen School of Medicine at UCLA
Learn More & Join Trial
Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) PHASE3 This is a Phase 3 trial to evaluate the efficacy and safety of 30 milligram...
Show More Location
University of Alabama at Birmingham Hospital
Learn More & Join Trial
Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD) PHASE3 To evaluate the efficacy and safety of pamrevlumab versus placebo in combin...
Show More Location
Arkansas Children's
Learn More & Join Trial
Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS) PHASE1 The purpose of this study is to evaluate the safety and tolerability of FG-...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy PHASE1 The purpose of this study is to evaluate the safety and tolerability of two...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease PHASE2 This study evaluates the efficacy and safety of intravenous (IV) infusions ...
Show More Learn More & Join Trial
Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD PHASE3 To evaluate the efficacy and safety of pamrevlumab versus placebo in combin...
Show More Location
Arkansas Children's Hospital
Learn More & Join Trial
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) PHASE3 This is a Phase 3 trial to evaluate the efficacy and safety of 30 milligram...
Show More Location
UAB Lung Health Center
Learn More & Join Trial
Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis PHASE1 The main purpose of this study is to evaluate the safety, tolerability, pha...
Show More Location
National Jewish Medical and Research Center
Learn More & Join Trial